Elicio Therapeutics, Inc. — Form D
Elicio Therapeutics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-17. The offering totals $35.0M, of which $15.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-07-17
- Form: D
- Accession: 0001601485-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $35.0M
- Amount sold: $15.4M
- Remaining: $19.6M
- Minimum investment: $15K
- Investors: 133
- Date of first sale: 2018-07-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-317100
Issuer
- Name: Elicio Therapeutics, Inc.
- CIK: 0001601485
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 451 D Street, Boston, MA, 02210
- Phone: (857) 209-0050
Officers, directors & promoters (24)
| Name | Role | Location |
|---|
| Jay D Venkatesan | Director | Uniondale, NY |
| Michael D Yamin | Director | Uniondale, NY |
| Jay D Venkatesan | Executive Officer | Uniondale, NY |
| Yekaterina Chudnovsky | Director | LOS ANGELES, CA |
| Karen Wilson | Director | Boston, MA |
| Christopher Haqq | Executive Officer | Boston, MA |
| Jay Venkatesan | Director | Boston, MA |
| Carol Ashe | Director | Boston, MA |
| Brian Piekos | Executive Officer | Boston, MA |
| Robert Connelly | Director | Boston, MA |
| Robert Connelly | Executive Officer | Boston, MA |
| Allen Nissenson | Director | Boston, MA |
| Robert Ruffolo | Director | Boston, MA |
| Peter DeMuth | Executive Officer | Boston, MA |
| Julian Adams | Director | Boston, MA |
| Allen R Nissenson | Director | San Francisco, CA |
| Jay R Venkatesan | Director | San Francisco, CA |
| Jay R Venkatesan | Executive Officer | San Francisco, CA |
| Karen R Wilson | Director | San Francisco, CA |
| Itzhak D Goldberg | Director | Uniondale, NY |
| Itzhak D Goldberg | Executive Officer | Uniondale, NY |
| Victor R Ganzi | Director | San Francisco, CA |
| Gil R Omenn | Director | San Francisco, CA |
| Michael R Yamin | Director | Uniondale, NY |
Other filings by this issuer (7)
More